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Background: Whether microalbuminuria (MICRO) in non-diabetic patients with metabolic syndrome (METS) influences markers of atherosclerosis 
such as carotid artery intimal-medial thickness (IMT) and distensibility (CADC) is unknown.
Methods: The study comprised 6814 asymptomatic men and women (52.85%), aged 45-84 yrs without prior cardiovascular disease, enrolled in 
the Multi-Ethnic Study of Atherosclerosis [MESA]. All patients underwent urine albumin-creatinine ratio and carotid artery ultrasound at baseline. The 
5907 non-diabetic individuals were divided based on the presence/absence of METS (NCEP criteria) and MICRO (30-300 mg/g) into 4 groups: 1) 
No METS + No MICRO (reference group) [70%] 2) MICRO-only [4%] 3) METS-only [23.3%] 4) METS+MICRO [2.7%]. Association with internal carotid 
IMT ≥75th percentile and CADC ≤ 25th percentile were examined using multivariate logistic regression.
Results: Prevalence of CADC<25 pct and IMT > 75 pct were highest in METS+MICRO group (52.63%, 47.68%) compared to METS-only (26.91%, 
31.67%) and reference group (19.68%, 21.64%). METS+MICRO were more predictive of CADC than METS alone in all races. However in sub-group 
analysis, association with IMT was seen only in whites (Table 1).
Conclusions: Microalbuminuria in non-diabetic patients with metabolic syndrome is an incremental predictor of subclinical atherosclerosis in the 
large majority of ethnic subgroups, and might explain recent findings of worse cardiovascular outcomes in this subpopulation. 
Crude and adjusted Odds Ratio (OR) estimates β associated with metabolic syndrome and microalbuminuria
CADC<25 pct CADC range η IMT > 75 pct IMT range ( mm)
Group OR 95% CI Mean (Min-Max) OR 95% CI Mean (Min-Max)
A. Unadjusted OR
MICRO only 2.791 2.120-3.675* 2.1 (0.5-100) 1.493 1.110-2.008* 1.109 (0.382-4.428)
METS only 1.503 1.301-1.737* 2.3 (0.448-100) 1.678 1.463-1.925* 1.135 (0.38-5.402)
MICRO+METS 4.535 3.268-6.295* 1.93 (0.49-5.8) 3.298 2.376-4.578* 1.309 (0.44-3.358)
B. Adjusted for age, gender and ethnicity
MICRO only 1.899 1.403-2.571* --- 1.04 0.759-1.425 ---
METS only 1.389 1.185-1.628* --- 1.755 1.516-2.032* ---
MICRO+METS 2.85 1.976-4.110* --- 2.358 1.659-3.352* ---
C. Adjusted for above variables and known confounders†
MICRO only 1.835 1.326-2.539* --- 0.966 0.687-1.358 ---
METS only 1.345 1.133-1.597* --- 1.447 1.232-1.700* ---
MICRO+METS 2.506 1.695-3.707* --- 2.139 1.464-3.125* ---
D. Race stratified analysis adjusted for age and gender
Whites METS only 1.612 1.239-2.097* 2.46 (0.58-8.43) 1.543 1.201-1.982* 1.21 (0.383-5.402)
MICRO+METS 2.731 1.387-5.380* 2.1 (0.88-4.45) 3.678 1.937-6.985* 1.56 (0.551-3.118)
Chinese METS only 1.494 0.843-2.645 2.2 (0.77-6.97) 1.022 0.590-1.768 0.866 (0.396-3.197)
MICRO+METS 6.006 1.843-19.57* 1.77 (0.57-5.6) 0.693 0.228-2.106 0.94 (0.44-2.085)
Blacks METS only 1.39 0.996-1.941 2.24 (0.448-100) 1.248 0.903-1.726 1.179 (0.443-4.38)
MICRO+METS 2.166 1.007-4.902* 2.04 (0.77-5.79) 1.246 0.554-2.803 1.233 (0.547-3.195)
Hispanics METS only 1.138 0.793-1.633 2.26 (0.473-6.5) 1.633 1.170-2.278* 1.049 (0.38-3.814)
MICRO+METS 4.603 2.063-10.270* 1.78 (0.49-4.27) 2.104 0.991-4.465 1.238 (0.475-3.357)
† Adjusted in addition for smoking, family history of cardiovascular disease, LDL, antihypertensive medications, statin therapy, and serum creatinine. 
β In comparison to reference group (No METS + No MICRO)
η Units: (1/ Kilo Pascals) x 10-3 
* Statistically significant
